Article

Thyroid disorder may heighten risk of glaucoma

Patients with glaucoma were 38% more likely to have had a thyroid disorder at some point in their lives than those without, according to a study published in the British Journal of Ophthalmology.

Birmingham, AL-Patients with glaucoma were 38% more likely to have had a thyroid disorder at some point in their lives than those without, according to a study published in the British Journal of Ophthalmology. Statistics were gathered from 12,376 people who participated in the 2002 National Health Interview Survey.

Participants were asked whether they ever had been diagnosed with a thyroid gland disorder or glaucoma. Slightly more than 4.5% of participants said glaucoma was diagnosed and 12% said a thyroid problem was diagnosed. The percentage of patients with glaucoma who said they had suffered a thyroid problem was 6.5% to 4.4% who had not.

An underactive thyroid can promote chemical deposits in the blood vessels serving the eye, which can spark an increase in IOP, said study authors.

Patients with thyroid problems should see an ophthalmologist or make their ophthalmologist aware of their thyroid condition, said lead researcher Gerald McGwin, PhD, vice chairman of the Department of Ophthalmology, University of Alabama School of Medicine, Birmingham.

"Somebody who has a history of thyroid problems and has not seen an ophthalmologist may have a heightened level of concern about their eyesight," he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.